The National Comprehensive Cancer Network (NCCN) Foundation announced Dr. Tim Luetkens in the Division of Hematology and Hematologic Malignancies as a recipient of the 2018 Young Investigator Awards. The NCCN Foundation selects 4 young investigators at the forefront of their field each year to support their career development. These highly qualified researchers are noted for their innovative ideas in improving the quality, effectiveness, and efficiency of care provided to cancer patients. Dr. Luetkens’ innovative research in the laboratory of Professor Djordje Atanackovic focuses on CD229 CAR T cell immunotherapy in Multiple Myeloma. Dr. Luetkens will be awarded $150,000 over a two-year period to support his innovative work.... Read MoreInternal Medicine
Division of Hematology & Hematologic Malignancies
The scientific focus of our division is the study of blood and bone marrow in health and disease. Our physicians treat patients with blood cancer, such as leukemias and lymphomas; clotting disorders, such as hemophilia; and diseases of iron metabolism, such as hemochromatosis. Starting with Maxwell Wintrobe, one of the founding fathers of Hematology and the University of Utah Medical School, our division can look back at a long-standing tradition of excellence in research, clinical care and teaching.
Congratulations to Dr. Paul Shami on his appointment as Research Compliance Office Medical Director. Dr. Shami will also chair the Data and Safety Monitoring Committee and will provide leadership to the Research Compliance Office in ensuring safe, ethical, and responsible conduct of clinical research at HCI.... Read MoreInternal Medicine
The Division of Hematology and Hematologic Malignancies awarded pilot research grants of $40,000 to four faculty. We congratulate Drs. Paul Bray, Tim Luetkens, Doug Sborov and Mike Deininger for their selections as awardees. ... Read MoreInternal Medicine
The Hematology Division enjoyed a group hike up to Dog Lake in the Wasatch Mountains on September 26. A recent snowfall resulted in a beautiful hike on a snow packed trail. ... Read MoreInternal Medicine
Congratulations to Drs. Mike Deininger and Thomas O'Hare for their receipt of a three year V Foundation Translational Grant award on Targeting SIRT5 in Acute Myeloid Leukemia. The V Foundation for Cancer Research was founded by legendary basketball coach Jim Valvano with the goal of achieving victory over cancer through research.... Read MoreInternal Medicine
Dr. Paul Shami and JSK Therapeutics were granted an award from the Small Business Innovation Research Program of the National Cancer Institute to conduct IND-enabling studies of their nitric oxide-generating drug JS-K. JS-K has shown efficacy in animal models of acute myeloid leukemia, multiple myeloma, non-small cell lung cancer and several other solid tumors. Completion of work conducted with this award will allow initiation of Phase I clinical trials of this first-in-class anti-cancer agent. Congratulations to Dr. Shami and his team for this Direct-to-Phase II SBIR award. ... Read MoreInternal Medicine